Predictors of Postoperative ICU Admission in Patients With COVID-19-Associated Mucormycosis

被引:0
|
作者
Gupta, Vibhor [1 ,2 ]
Yadav, Aman [1 ,2 ]
Chilkoti, Geetanjali T. [1 ,2 ]
Mohta, Medha [1 ,2 ]
Meena, Rajesh K. [3 ]
机构
[1] Univ Delhi, Univ Coll Med Sci, Anesthesiol & Crit Care, New Delhi, India
[2] Guru Tegh Bahadur Hosp, New Delhi, India
[3] Banaras Hindu Univ, Anaesthesia, Varanasi, India
关键词
invasive ventilation; icu fatality; steroids; perioperative factors; icu; comorbidity; covid-19 associated mucormycosis; MANAGEMENT;
D O I
10.7759/cureus.29543
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Studies exploring factors predicting postoperative ICU requirement in patients with coronavirus disease 2019 (COVID-19)-associated mucormycosis (CAM) were not found in the literature. The aim was to evaluate the demographic profile, comorbidities, pattern of steroid received, airway assessment, and intraoperative hemodynamic perturbations associated with ICU requirement amongst patients scheduled for sinonasal debridement.Methods: This is a retrospective cohort study. All CAM patients of >= 18 years were included. The patients' characteristics, comorbidities, pattern of steroid received, airway assessment, intraoperative hemodynamic perturbations, and outcome data were retrieved.Results: A total of 130 patients were included. Thirty got admitted to ICU, out of which 26 expired. Amongst the various comorbidities, diabetes was the most common (93.85%) and was associated with higher chances of ICU requirement. Of patients with a history of steroid intake, 71% had a significantly higher risk of ICU admission. Out of 30 patients admitted to ICU, 87% (n=26) received invasive ventilation, and the rest were admitted for observation only.Conclusion: Middle age, uncontrolled diabetes, history of steroid intake, increased levels of serum creatinine with low potassium, and increased total leucocyte count are the independent risk factors predicting postoperative ICU admission amongst patients with CAM scheduled for sinonasal debridement.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Relapse of COVID-19-associated mucormycosis in patients receiving posaconazole as maintenance treatment
    Salehi, Mohammadreza
    Khodavaisy, Sadegh
    Sarvestani, Hasti Kamali
    Sobati, Abolfazl
    Pakdel, Farzad
    Fard, Elahe Samiee
    Darvishi, Marzieh
    Shavandi, Mehrdad
    Mussini, Cristina
    Rafat, Zahra
    Ahmadikia, Kazem
    Tabari, Azin
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (09): : s163 - s169
  • [22] Facial Nerve Palsy in COVID-19-Associated Mucormycosis Patients: A Case Series
    Mehta, Rupa
    Nagarkar, Nitin M.
    Sasanka, Krishna K. S. B. S.
    Sudha, Sree T. Y.
    Arora, Ripu Daman
    Aggarwal, Aakash
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [23] Deficient Phagocytosis in Circulating Monocytes from Patients with COVID-19-Associated Mucormycosis
    Sinha, Bishnu Prasad
    Mehta, Priyanka
    Hoque, Md Asmaul
    Bandopadhyay, Purbita
    Nandi, Ayandip
    Saha, Ipsita
    Mitra, Anita Nandi
    Mondal, Asish
    Bhattacharjee, Boudhayan
    Chamilos, Georgios
    Pandey, Rajesh
    Basu, Kaushik
    Ganguly, Dipyaman
    MBIO, 2023, 14 (03):
  • [24] Commentary: Combating COVID-19-associated mucormycosis with limited resources
    Kim, Usha
    Kulkarni, Pooja
    Saini, Pragya
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2022, 70 (06) : 2169 - 2169
  • [25] COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping
    Hussain, Salman
    Baxi, Harveen
    Riad, Abanoub
    Klugarova, Jitka
    Pokorna, Andrea
    Slezakova, Simona
    Licenik, Radim
    Najmi, Abul Kalam
    Klugar, Miloslav
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (19)
  • [26] Renal infarction due to COVID-19-associated renal mucormycosis
    Kurien, Anila Abraham
    Srinivasaprasad, Nagalakshmi Dhanapal
    Valavan, Kaliyaperumal Thirumal
    KIDNEY INTERNATIONAL, 2022, 101 (03) : 655 - 655
  • [27] COVID-19-associated mucormycosis: An updated systematic review of literature
    Pal, Rimesh
    Singh, Birgurman
    Bhadada, Sanjay Kumar
    Banerjee, Mainak
    Bhogal, Ranjitpal Singh
    Hage, Neemu
    Kumar, Ashok
    MYCOSES, 2021, 64 (12) : 1452 - 1459
  • [28] COVID-19-associated disseminated mucormycosis: An autopsy case report
    Daisuke Kyuno
    Terufumi Kubo
    Mitsuhiro Tsujiwaki
    Shintaro Sugita
    Michiko Hosaka
    Hazuki Ito
    Keisuke Harada
    Akira Takasawa
    Yusaku Kubota
    Kumi Takasawa
    Yusuke Ono
    Kazufumi Magara
    Eichi Narimatsu
    Tadashi Hasegawa
    Makoto Osanai
    World Journal of Clinical Cases, 2022, 10 (28) : 10358 - 10365
  • [29] Distinguishing Characteristics of COVID-19-Associated Mucormycosis; a Case Series
    Samimiardestani, Seyedhadi
    Irani, Shirin
    Hasibi, Mehrdad
    Seyedahadi, Maral
    Bastaninejad, Shahin
    Firouzifar, Mohammadreza
    Ardehali, Mojataba Mohammadi
    Berijani, Sina
    Erfanian, Reza
    Kazemi, Mohammad Ali
    Etemadi-Aleagha, Afshar
    Rahimi, Abolfazl
    Yarandi, Kourosh Karimi
    Ahadi, Samira
    ARCHIVES OF ACADEMIC EMERGENCY MEDICINE, 2022, 10 (01)
  • [30] COVID-19-Associated Mucormycosis: A Battle Against Fatal Menace
    Sanchetee, Pratap
    Rajan, Rajeswari
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2022, 25 (03) : 336 - 337